Blog
Pearl IRB COVID-19 Response
The Centers for Disease Control and Prevention (CDC) has recommended the implementation of several community actions in an effort to reduce people’s risk of being exposed to COVID-19. These actions slow the spread, reduce the impact of disease (i.e.,...
Single IRB – A Guide for the Common Rule sIRB Mandate
The revised Federal Policy for the Protection of Human Subjects (the “Common Rule”) collaborative (multi-site) research provision requires that U.S. institutions engaged in cooperative research conducted or supported by a Common Rule agency must rely on a single IRB...
Acting with integrity within the sometimes-unethical pharmaceutical industry
Book: Bottle of Lies: The Inside Story of the Generic Drug Boom, by Katherine Eban Good read. I honestly forgot about the phone call I had with Katherine Eban more than 5 years ago, so it took me by surprise to see my name in her book. Yes, right there on page 224 in...
ICH releases updated draft guideline for general considerations for clinical studies
The International Council for Harmonization (ICH) released an updated version of its guideline on general considerations for clinical trials, RAPS reports. ICH released the guideline, E8(R1), earlier this May for public consultation on the draft.The...
Meet Pearl IRB at ACRP 2019 in Nashville, TN
Pearl IRB will attend and exhibit at the upcoming Association of Clinical Research Professionals (ACRP) 2019 conference. The event takes place April 12 - 15 in Nashville, Tennessee. Stop by our booth (#549) to meet our team! About ACRP 2019 ACRP 2019 brings the...